Governments are requesting the assistance of the United Nations to quantify the national-level costs of treating NCDs, the costs of NCD burdens on the economy, the costs of interventions to prevent and control NCDs, and the return on investment (ROI) of those interventions. Heads of State and Government or their representatives have committed to develop national NCD investment cases in the 2018 ‘Political declaration of the third high-level meeting of the General Assembly on the prevention and control of NCDs’. The Task Force’s investment case work is led by the WHO-UNDP NCD2030 Programme.

There are two components to an NCD investment case – an economic component and an institutional and context analysis (ICA). The two guidance notes below focuses on how to undertake the economic component of NCD investment cases but also provide guidance on undertaking the ICA. Economists working on an NCD investment case within the context of NCD2030 are expected to be familiar with the WHO OneHealth Tool.